[1] | US National Science Foundation (2012) Academic Research and Development. In: Science and Engineering Indicators 2012. National Science Foundation. Appendix 5–41.
|
[2] | Narin F, Stevens K, Whitlow E (1991) Scientific co-operation in Europe and the citation of multinationally authored papers. Scientometrics 21: 313–323.
|
[3] | Katz S, Hicks D (1997) How much is a collaboration worth? A calibrated bibliometric model. Scientometrics 40: 541–554.
|
[4] | Goldfinch S, Dale T, DeRouen K (2003) Science from the periphery: collaboration, networks, and periphery effects in the citation of New Zealand Crown Research Institutes articles, 1995–2000. Scientometrics 57: 321–337.
|
[5] | Gl?nzel W, Schubert A (2005) Domesticity and internationality in co-authorship, references and citations. Scientometrics 65: 323–342.
|
[6] | Luo J, Flynn JM, Solnick RE, Ecklund EH, Matthews KRW (2011) International stem cell collaboration: how disparate policies between the United States and the United Kingdom impact research. PLoS ONE 6: e17684. Available: http://www.plosone.org/article/info%3Ado?i%2F10.1371%2Fjournal.pone.0017684. Accessed 2013 Aug 1.
|
[7] | Flynn JM, Matthews KRW (2010) Stem cell research in the Greater Middle East: the importance of establishing policy and ethics interoperability to foster international collaborations. Stem Cell Rev and Rep 6: 143–150.
|
[8] | Price DS (1986). Little Science, Big Science…and Beyond. New York, NY: Columbia University Press.
|
[9] | Katz JS (1994) Geographic proximity and scientific collaboration. Scientometrics 31: 31–43.
|
[10] | Luukkonen T, Persson O, Sivertsen G (1992) Understanding patterns of international scientific collaboration. Science, Technology, and Human Values 17: 101–126.
|
[11] | US National Science Foundation (2010) Globalization of Science and Engineering Research. In: Science and Engineering Indicators 2010. National Science Foundation. Science and Engineering Indicators Companion.
|
[12] | Li L, Ding G, Feng N, Wang M, Ho Y (2009) Global stem cell research trend: bibliometric analysis as a tool for mapping of trends from 1991 to 2006. Scientometrics 80: 39–58.
|
[13] | Newman MEJ (2004) Coauthorship networks and patterns of scientific collaboration. PNAS 101: 5200–5205.
|
[14] | Wallace ML, Larivière V, Gingras Y (2012) A small world of citations? The influence of collaboration networks on citation practices. PLoS One 7: e33339.Available: http://www.plosone.org/article/info%3Ado?i%2F10.1371%2Fjournal.pone.0033339. Accessed 2013 Aug 1.
|
[15] | US National Institutes of Health (2009) Stem cell basics: what are stem cells, and why are they important. Available: http://stemcells.nih.gov/info/basics. Accessed 2013 Aug 1.
|
[16] | Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 1–12.
|
[17] | Ben-David U, Kopper O, Benvenist N (2012) Expanding the Boundaries of Embryonic Stem Cell Research. Cell Stem Cell 10: 666–677.
|
[18] | CNN (2001) President George W. Bush’s address on stem cell research. CNN Politics Transcript. Available: http://edition.cnn.com/2001/ALLPOLITICS/?08/09/bush.transcript/index.html. Accessed 2012 Apr 26.
|
[19] | Obama B (2009) Executive order 13505: Removing barriers to responsible scientific research involving human stem cells. Federal Register 74: 10667–10668.
|
[20] | Human Fertilization and Embryology Authority (1990) The human fertilization and embryology act of 1990. Available: http://www.hfea.gov.uk/2070.html. Accessed 2011 Dec 8.
|
[21] | Widermann P, Simon J, Schichtanz S, Tannert C (2004) The future of stem cell in Germany. EMBO Reports 5: 927–931.
|
[22] | Herrmann I, Woopen C, Brüstle O (2008) Germany parliament passes amendment to Stem Cell Act. Eurostemcell. Available: http://www.eurostemcell.org/commentanaly?sis/german-parliament-passes-amendment-s?tem-cell-act. Accessed 2012 Aug 4.
|
[23] | Matthews KRW (2009) Stem cell research: a science and policy overview. Baker Institute for Public Policy Report. Available: http://www.bakerinstitute.org/publicatio?ns/stemcell-intro-0208.pdf. Accessed 2011 Dec 8.
|
[24] | Liao LM, Li LS, Zhao RC (2007) Stem cell research in China. Philosophical Transactions of the Royal Society B: Biological Sciences. 362: 1107–1112.
|
[25] | Cyranoski D (2012) China’s stem-cell rules go unheeded. Nature News. Available at: http://www.nature.com/news/china-s-stem-?cell-rules-go-unheeded-1.10410. Accessed 2013 Jun 7.
|
[26] | Ho YS, Chiu CH, Tseng TM, Chiu WT (2003) Assessing stem cell research productivity.”. Scientometrics 57: 369–376.
|
[27] | Carlstein S (2010) Databases for bibliometric analysis. J?nk?ping University. Available: http://hj.se/bibl/en/publishing/bibliome?trics/databases-for-bibliometric-analysi?s.html. Accessed 2012 Apr 25.
|
[28] | Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.
|
[29] | Amin M, Mabel M (2000) Impact factors: use and abuse. Perspectives in Publishing. Available: http://www.elsevier.com/framework_editor?s/pdfs/Perspectives1.pdf. Accessed 2012 Apr 24.
|
[30] | Garfield E (1994) The Thomson Reuters Impact Factor. Available: http://thomsonreuters.com/products_servi?ces/science/free/essays/impact_factor/. Accessed 2012 Apr 25.
|
[31] | Abt H (1984) Citations to single and multiauthored papers. Publication of the Astronomical Society of the Pacific. 96: 746–749.
|
[32] | Smart J, Bayer A (1986) Author collaboration and impact: a note on citation rates of single and multiple authored articles. Scientometrics 10: 297–305.
|
[33] | Herbertz H (1995) Does it pay to cooperate? A bibliometric case study in molecular biology. Scientometrics 33: 117–122.
|
[34] | Gl?nzel W (2002) Coauthorship patterns and trends in the sciences (1980–1998): a bibliometric study with implications for database indexing and search strategies. Library Trends. 50: 461–473.
|
[35] | US National Institutes of Health (2010) Stem Cells and Diseases. Available: http://stemcells.nih.gov/info/basics/bas?ics6.asp. Accessed 2011 Dec 5.
|
[36] | US National Science Foundation (2012) R&D: National Trends and International Comparisons. In: Science and Engineering Indicators 2012. National Science Foundation.
|
[37] | Doring O (2003) China’s struggle for practical regulations in medical ethics. Nat Rev Genet 4: 233–239.
|
[38] | McMahon D, Thorsteinsdóttir H, Singer PA, Daar A (2010) Cultivating regenerative medicine innovation in China. Reg Med 10: 35–44.
|
[39] | Salter B, Cooper M, Dickins A (2006) China and the global stem cell bioeconomy: an emerging political strategy? Regen Med 1: 671–783.
|
[40] | Doring O (2004) Chinese researchers promote biomedical regulations: what are the motives of the biopolitical dawn in China and where are they heading? Kennedy Instit Ethics J. 14: 39–46.
|
[41] | Ministry of Health of the People’s Republic of China (2009) Clinical application of technology management approach. Available: http://www.moh.gov.cn/publicfiles/busine?ss/htmlfiles/mohyzs/s3585/200903/39511.h?tm. Accessed 2012 Jul 29.
|
[42] | US National Science Foundation (2012) Academic Research and Development. In: Science and Engineering Indicators 2012. National Science Foundation.
|
[43] | Zweig D, Wang H (2012) Can China bring back the best? The Communist Party organizes China’s search for talent. China Quarterly. Available: http://www.google.com/url?sa=t&rct=j&q=&?esrc=s&source=web&cd=1&cad=rja&ved=0CCwQ?FjAA&url=http%3A%2F%2Fwww.sosc.ust.hk%2F?community_corner%2Fpdf%2FDavid%2520Zweig?%2520Working%2520Paper%2520May%25202012.?pdf&ei=f436UZ6wNZCe9QTQvoDABA&usg=AFQjCN?Ghti66-TN0qEXvGBv2SWITJbpJwg&bvm=bv.5016?5853,d.eWU. Accessed 2013 Aug 1.
|
[44] | European Commission (2002) Work Programme – specific extract for Thematic Priority 1: life sciences, genomics and biotechnology for health. Available: ftp://ftp.cordis.europa.eu/pub/fp6/docs/?wp/sp1/a_wp_200201_en.pdf. Accessed 2012 Aug 2.
|
[45] | European Commission (2005) Proposal for a council decision concerning the specific programme cooperation implementing the seventh framework programme. (2007–2013): 440.
|
[46] | United Kingdom Human Tissue Authority (2008) Stem cell science in the UK: key facts about research, regulation, and funders. Available: http://www.hta.gov.uk/_db/_documents/ste?m_cell_pack_200806170144.pdf.
|
[47] | International Stem Cell Banking Initiative (2009) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev and Rep 5: 301–314.
|
[48] | Tansey B (2008) State, United Kingdom team for stem cell work. San Francisco Chronicle. Available: http://www.sfgate.com/business/article/S?tate-United-Kingdom-team-for-stem-cell-w?ork-3264981.php. Accessed 2013 Jun 7.
|
[49] | Isasi RM, Knoppers BM (2006) Beyond the permissibility of embryonic and stem cell research: substantive requirements and procedural safeguards. Hum Reprod 21: 2474–2481.
|
[50] | Schuldt BM, Guhr A, Lenz M, Kobold S, MacArthur BD, et al.. (2013) Power-laws and the use of pluripotent stem cell lines. PLoS ONE 8(1): e52068.Available: http://www.plosone.org/article/info%3Ado?i%2F10.1371%2Fjournal.pone.0052068 Accessed 2013 Aug 1.
|
[51] | L?ser P, Schirm J, Guhr A, Wobuse AM, Kurtz A (2009) Human embryonic stem cell lines and their use in international research. Stem Cells 28: 240–46.
|